| mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.9 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |
| mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
| mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.9 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |